Karolin Isaksson
41 – 50 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
- Contribution to journal › Article
-
Mark
Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
- Contribution to journal › Article
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
- Contribution to journal › Article
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- Contribution to journal › Article
-
Mark
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
- Contribution to journal › Article
-
Mark
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
- Contribution to journal › Article
-
Mark
Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition
- Contribution to journal › Article
